3.76 +0.00 (0.00%)
NKTR
Stock Details
Last Trade:3.76 Change:+0.00 (0.00%) Prev Close:3.76 Open: 4.18 Days Range:3.75 – 4.42 52 Week Range: 2.45 - 7.67 Volume:372192 P/E: N/AEPS:-0.78
View AllRecent Alerts 11/20/08
Recent Alert on 11/06/08 at 5:05pm
Nektar Therapeutics (NKTR) Reports Q3 Loss of $0.40
Nektar Therapeutics (NKTR) Reports Q3 Loss of $0.40
Nektar Therapeutics (Nasdaq: NKTR) reports Q3 loss of $0.40, versus the analyst estimate of ($0.29). Revenue for the quarter was $21.4 million, versus the consensus of $25.76 million.
Recent Alert on 10/21/08 at 10:44am
Notable Mergers and Acquisitions of the Day 10/21: NKTR/NVS, SYT, IEX
Notable Mergers and Acquisitions of the Day 10/21: NKTR/NVS, SYT, IEX
Recent Alert on 10/21/08 at 9:53am
Nektar (NKTR) Sells Pulmonary Delivery Assets to Novartis for $115M
Nektar (NKTR) Sells Pulmonary Delivery Assets to Novartis for $115M
Recent Alert on 10/21/08 at 9:53am
Nektar (NKTR) Sells Pulmonary Delivery Assets to Novartis for $115M
Nektar (NKTR) Sells Pulmonary Delivery Assets to Novartis for $115M
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 05/05/08 at 8:01am
Generex Biotech's Oral-lyn Granted Special Access Authorization by Health Canada
Generex Biotech's Oral-lyn Granted Special Access Authorization by Health Canada